TMCnet News

Non-Melanoma Skin Cancer - Forecast in 8 Major Markets 2016-2026 - Research and Markets
[September 30, 2016]

Non-Melanoma Skin Cancer - Forecast in 8 Major Markets 2016-2026 - Research and Markets


Research and Markets has announced the addition of the "Non-Melanoma Skin Cancer Forecast in 8 Major Markets 2016-2026" report to their offering.

Non-melanoma skin cancer (NMSC) is cancer of the skin not arising from melanocytes. It is one of the most frequently occurring cancers, although it tends not to be reported via registries as prognosis for patients is good in most cases.

There are two main types of NMSC malignancies; Basal Cell Carcinoma (BCC (News - Alert)) and Squamous Cell Carcinoma (SCC). BCC is the more predominant type and are a heterogeneous group of tumours ranging from superficial to deeply invasive tumours than can be life threatening.

This report provides the current prevalent population for Non-melanoma skin cancer across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report also cotains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.



Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of Non-melanoma skin cancer have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

People with certain skin conditions may also have an increased risk of developing skin cancer. These conditions include:


  • Psoriasis
  • Solar Keratosis (aka actinic keratosis)
  • Xeroderma Pigmentosum

Key Topics Covered:

1. Introduction

2. Cause of the Disease

3. Risk Factors & Prevention

4. Diagnosis of the Disease

5. Variation by Geography/Ethnicity

6. Disease Prognosis (News - Alert) & Clinical Course

7. Key Co-morbid Conditions/Features Associated with the Disease

8. Methodology for Quantification of Patient Numbers

9. Top-line incidence for non-melanoma skin cancer patients

10. Abbreviations used in the Report

11. Patient-Based Offering

12. Online Pricing Data and Platforms

13. References

14. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/82hv5m/nonmelanoma_skin


[ Back To TMCnet.com's Homepage ]